A unique experiment is being prepared in Ostrava. For the first time in the Czech Republic, physicians will study the effect of hydrogen on the risk and early symptoms of Alzheimer’s dementia. Inhaling molecular hydrogen may help delay memory problems and improve quality of life. The clinical study has already received all necessary approvals and is now seeking participants.
H2 Medical Technologies is issuing a public call for volunteers who wish to take part in the study and meet the basic criteria: age 50–80 years, overall good health, a diagnosis of mild cognitive impairment or mild to moderate dementia, and ideally residence in Ostrava or the surrounding area where the study will take place. Participation in this study does not guarantee any health benefit and should not be understood as a substitute for standard medical treatment.
Interested individuals may apply by January 19, 2026, by contacting:
📧 david.skoloudik@H2medical.com
You can find the interview and the full article here: